Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models

被引:32
|
作者
Alam, Imranul [1 ]
Gray, Amie K. [2 ]
Chu, Kang [2 ]
Ichikawa, Shoji [2 ]
Mohammad, Khalid S. [2 ]
Capannolo, Marta [4 ]
Capulli, Mattia [4 ]
Maurizi, Antonio [4 ]
Muraca, Maurizio [5 ]
Teti, Anna [4 ]
Econs, Michael J. [2 ,3 ]
Del Fattore, Andrea [5 ]
机构
[1] Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA
[3] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[4] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy
[5] Bambino Gesu Pediat Hosp, Regenerat Med Unit, Ist Ricovero Cura Carattere Sci, I-00165 Rome, Italy
关键词
Osteopetrosis; Autosomal dominant osteopetrosis; Osteoclast; Chloride channel 7; Mouse model; ALBERS-SCHONBERG-DISEASE; CHLORIDE CHANNEL; MUTATIONS; CLC-7; BIOLOGY; CIC-7; LEADS; GENE;
D O I
10.1016/j.bone.2013.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant osteopetrosis type II (ADO2) is a heritable osteosclerotic disorder dependent on osteoclast impairment. In most patients it results from heterozygous missense mutations in the chloride channel 7 (CLCN7) gene, encoding for a 2Cl(-)/1H(+) antiporter. By a knock-in strategy inserting a missense mutation in the Clcn7 gene, our two research groups independently generated mouse models of ADO2 on different genetic backgrounds carrying the homolog of the most frequent heterozygous mutation (p.G213R) in the Clcn7 gene found in humans. Our results demonstrate that the heterozygous model holds true presenting with higher bone mass, increased numbers of poorly resorbing osteoclasts and a lethal phenotype in the homozygous state. Considerable variability is observed in the heterozygous mice according with the mouse background, suggesting that modifier genes could influence the penetrance of the disease gene. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 75
页数:10
相关论文
共 50 条
  • [41] Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2
    Capulli, Mattia
    Maurizi, Antonio
    Ventura, Luca
    Rucci, Nadia
    Teti, Anna
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : 1 - 13
  • [42] ULTRASTRUCTURAL INVESTIGATIONS OF BONE RESORPTIVE CELLS IN 2 TYPES OF AUTOSOMAL-DOMINANT OSTEOPETROSIS
    BOLLERSLEV, J
    MARKS, SC
    POCKWINSE, S
    KASSEM, M
    BRIXEN, K
    STEINICHE, T
    MOSEKILDE, L
    BONE, 1993, 14 (06) : 865 - 869
  • [43] Exclusion of the chromosomal 1p2l region in a large pedigree with a phenotypic variant of type II autosomal dominant osteopetrosis
    Bénichou, OD
    Van Hul, E
    Van Hul, W
    de Vernejoul, MC
    JOINT BONE SPINE, 2001, 68 (04) : 327 - 333
  • [44] Identification of two novel CLCN7 gene mutations in three Chinese families with autosomal dominant osteopetrosis type II
    Zheng, Hui
    Zhang, Zeng
    He, Jin-Wei
    Fu, Wen-Zhen
    Wang, Chun
    Zhang, Zhen-Lin
    JOINT BONE SPINE, 2014, 81 (02) : 188 - 189
  • [45] Enhanced Activation of Rac1/Cdc42 and MITF Leads to Augmented Osteoclastogenesis in Autosomal Dominant Osteopetrosis Type II
    Jung, Youn-Kwan
    Kwon, Ki-Tae
    Jang, Ji-Ae
    Han, Min-Su
    Kim, Gun-Woo
    Han, Seungwoo
    JBMR PLUS, 2019, 3 (02)
  • [46] Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications
    Norwood, Iona
    Szondi, Denis
    Ciocca, Michela
    Coudert, Amelie
    Cohen-Solal, Martine
    Rucci, Nadia
    Teti, Anna
    Maurizi, Antonio
    BONE, 2021, 144
  • [47] Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
    Kataoka, Hiroshi
    Akagawa, Hiroyuki
    Ushio, Yusuke
    Sato, Masayo
    Manabe, Shun
    Makabe, Shiho
    Kawachi, Keiko
    Akihisa, Taro
    Iwasa, Naomi
    Yoshida, Rie
    Tsuchiya, Ken
    Nitta, Kosaku
    Mochizuki, Toshio
    STROKE-VASCULAR AND INTERVENTIONAL NEUROLOGY, 2022, 2 (05):
  • [48] Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13
    Van Hul, E
    Gram, J
    Bollerslev, J
    Van Wesenbeeck, L
    Mathysen, D
    Andersen, PE
    VanHoenacker, F
    Van Hul, W
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (06) : 1111 - 1117
  • [49] Characteristics of ClC7 Cl- channels and their inhibition in mutant (G215R) associated with autosomal dominant osteopetrosis type II in native osteoclasts and hClcn7 gene-expressing cells
    Kajiya, Hiroshi
    Okamoto, Fujio
    Ohgi, Kimiko
    Nakao, Akihiro
    Fukushima, Hidefumi
    Okabe, Koji
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2009, 458 (06): : 1049 - 1059
  • [50] Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications
    Maurizi, Antonio
    Capulli, Mattia
    Curle, Annabel
    Patel, Rajvi
    Ucci, Argia
    Cortes, Juliana Alves
    Oxford, Harriet
    Lamande, Shireen R.
    Bateman, John F.
    Rucci, Nadia
    Teti, Anna
    BONE RESEARCH, 2019, 7 (1)